NorthStar Consulting
Dr. William K. Schmidt, Head, NorthStar Consulting, is the Parliamentarian and a Past-President of the Eastern Pain Association, the largest regional affiliate of the American Pain Society. He has over 25 years of pharmaceutical industry experience with a special emphasis on the discovery and development of novel analgesic and narcotic antagonist drugs. He was previously VP of Clinical Development for CrystalGenomics (Seoul, South Korea) and its U.S. subsidiary, CG Pharmaceuticals (Emeryville, CA); Senior VP of Development at Limerick BioPharma in South San Francisco, CA; VP, Clinical Research, for Renovis, Inc., in South San Francisco, CA; and VP, Scientific Affairs and Acting VP, Clinical R&D, at Adolor Corporation in Exton, PA. At Adolor, Dr. Schmidt was a key member of the team leading to the clinical development, NDA filing, and FDA approval of Entereg® (alvimopan), a peripherally-acting opioid antagonist. Currently as head of NorthStar Consulting, Dr. Schmidt serves as an expert on pain medicine pharmaceutical development with pharmaceutical and biotech companies throughout North America, Europe, Asia, Latin America, and Australia. Dr. Schmidt received a BA from the University of California Berkeley and his PhD University of California-San Francisco.
Current and Past Board Memberships
Dr. Schmidt serves as Member of Scientific Advisory Board at Urigen Pharmaceuticals, Inc. He serves as Member of Scientific and Medical Advisory Board at Cerimon Pharmaceuticals, Inc. He serves as Member of Medical Advisory Board at AcelRx Pharmaceuticals, Inc. He serves as a Member of Advisory Board at PainReform Ltd. He serves as ember of Scientific Advisory Board at Trevena, Inc. He previously served as Vice President of Clinical Research at Evotec
